期刊文献+

人参皂苷Rg3对乳腺癌细胞增殖的影响及其机制探讨 被引量:9

Research on the effect of ginsenoside Rg3 on proliferation of breast cancer cell line
下载PDF
导出
摘要 目的观察人参皂苷Rg3对乳腺癌细胞MDA-MB-231增殖的影响,并探讨其机制。方法取处于对数生长期的MDA-MB-231,加入不同终浓度(50、100、200、400、600μmol/L)人参皂苷Rg3,以不加人参皂苷Rg3为对照。MTT法检测细胞生长情况;Western blot法检测细胞中细胞周期蛋白E(Cyclin E)及细胞分裂周期蛋白25A(CDC25A)表达水平。结果低浓度(≤200μmol/L)的人参皂苷Rg3可促进MDA-MB-231增殖,高浓度(≥400μmol/L)的人参皂苷Rg3则抑制其增殖。与对照细胞比较,低浓度人参皂苷Rg3处理的细胞中Cyclin E及CDC25A的表达增高,高浓度处理者Cyclin E及CDC25A的表达下降(P均<0.01)。结论高浓度人参皂苷Rg3在体外对乳腺癌细胞的生长具有抑制作用,其机制可能与抑制细胞周期关键蛋白Cyclin E及CDC25A的表达有关。 Objective To investigate the effects of ginsenoside Rg3 on cell proliferation of breast cancer cell line MDA-MB-231 and the possible mechanism involved.Methods MDA-MB-231 cells at logarithmic growth phase were obtained,and were cultured with ginsenoside Rg3 of different concentrations(50、100、200、400、600 μmol/L).Cells cultured without ginsenoside Rg3 were served as controls.The proliferation of cells were detected by MTT assay,and the expression of Cyclin E and CDC25A was examined by Western blot,respectively.Results The growth rates on MDA-MB-231 cells treated with ginsenoside Rg3 of low concentration(≤200 μmol/L)increased,but those treated with ginsenoside Rg3 of high concentration(≥400 μmol/L)growed more slowly,compared with control group.The expression of cellular Cyclin E and CDC25A rose when exposed to ginsenoside Rg3 of low concentration(≤200 μmol/L)while declined when exposed to ginsenoside Rg3 of high concentration(≥400 μmol/L).Conclusions Ginsenoside Rg3 of high concentration(≥400 μmol/L)can inhibit the growth of MDA-MB-231.This effect may involve its suppression of cell-cycle related protein Cyclin E and CDC25A.
出处 《山东医药》 CAS 北大核心 2011年第26期20-22,共3页 Shandong Medical Journal
基金 国家自然科学基金青年科学基金资助项目(30500190) 山东省优秀中青年科学家科研奖励基金资助项目(2008BS03024) 山东省科技发展计划项目(2009GG10002012)
关键词 人参皂苷RG3 乳腺肿瘤 细胞增殖 细胞周期蛋白E 细胞分裂周期蛋白25A ginsenoside Rg3 breast neoplasms cell proliferation Cyclin E cell division cycle 25A protein
  • 相关文献

参考文献9

  • 1Jia WW, Bu X, Philips D, et al. Rh2, a compound extracted from ginseng, hypersensifizes multidrug-resistant tumor cells to chemotherapy[J]. Can J Physiol Pharmacol, 2004,82(7) :437.
  • 2Nakata H, Kikuehi Y, Tode T, et al. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells[ J]. Jpn J Cancer Res, 1998,89(7) :733-740.
  • 3Dapas B, Farra R, Grassi M, et al. Role of E2F1-Cyclin El-cyclin E2 circuit in human coronary smooth muscle cell proliferation and therapeutic potential of its downregulation by siRNAs[J]. Mol Med, 2009,15(9-10) :297-306.
  • 4Yasui W, Oue N, Aung PP, et al. Molecular-pathological prognostic factors of gastric cancer: a review [ J ]. Gastric Cancer, 2005,8 (2) :86-94.
  • 5Spruck C, Sun D, Fiegl H, et al. Detection of low molecular weight derivatives of cyelin E1 is a function of cyclin E1 protein levels in breast cancer [ J ]. Cancer Res, 2006,66 ( 14 ) :7355-7360.
  • 6Akli S, Keyomarsi K. Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy[ J]. Cancer Biol Ther, 2003,2(4 Suppl 1 ) :38-47.
  • 7DonzeUi M, Draetta GF. Regulating mammalian checkpoints through Cde25 inactivation [J]. EMBO Rep, 2003, 4 (7) : 671-677.
  • 8Lehmann GM, MeCabe MJ Jr. Arsenite slows S phase progression via inhibition of CDC25A dual specificity phosphatase gene tran- scription[ J]. Toxieol Sei, 2007,99( 1 ) :70-78.
  • 9Laveeehia A, Di Giovanni C, Novellino E. CDC25A and B dualspecificity phosphatase inhibitors : potential agents for cancer therapy [J]. Curr Med Chem, 2009,16(15) :1831-1849.

同被引文献125

引证文献9

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部